Skip to content

Efficacy evaluation of concurrent Zingiber and Vitamin B6 in morning sickness of pregnant women

Efficacy evaluation of concurrent Zingiber and Vitamin B6 in morning sickness of pregnant women

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017080635529N1
Enrollment
240
Registered
2017-09-30
Start date
2017-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

morning sickness. Vomiting of pregnancy, unspecified

Interventions

Intervention 1: Prescribing 250 mg of ginger and 20 mg of vitamin B6 orally twice daily for 4 days. Intervention 2: Prescribing 20 mg of vitamin B6 orally twice daily for 4 days. Intervention 3: Presc
Treatment - Drugs
Prescribing 250 mg of ginger and 20 mg of vitamin B6 orally twice daily for 4 days.
Prescribing 20 mg of vitamin B6 orally twice daily for 4 days.
Prescribing 500 mg of ginger and 20 mg of vitamin B6 orally twice daily for 4 days.

Sponsors

Deputy of Resaerch, TUMS
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Pregnant women with nausea or vomiting in the first 17 weeks of pregnancy; no other underlying conditions; no other medications; no history of hospitalization due to severe nausea and vomiting; no hyperemesis gravidarum; no history of hypersensitivity to ginger or vitamin B6; non pregnancy of twin or multiplexes. Exclsion criteria: Serious complications following the use of ginger and vitamin B6; Very severe nausea (hyperemesis gravidarum) during the study, which leads to hospitalization; other drugs used to control nausea.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of nausea. Timepoint: 2 time daily for 4 days. Method of measurement: Qualitative.

Secondary

MeasureTime frame
Reduce of vomiting severity by medication. Timepoint: 2 times daily for 4 days. Method of measurement: Qualitative.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid-Reza Adhami

TUMS

hr-adhami@tums.ac.ir+98 21 6412 1280

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026